-
Rules for Pick of The Year (PoTY) 2023
Happy New Year! Friends come and gather around and get your picks in. BlueWolf and I will continue our tradition to co-host the PoTY 2023.
You have until January 29, 2023 up to 11:59 PM PST to make a pick – Starting price will be January 30, 2023 closing price (per Google, unless it's shown that the Google price is incorrect). The contest will start on January 30, 2023. Any stocks trading on the NASDAQ, AMEX, NYSE or, OTC – Long or short.
We welcome IPOs if picked by the end of January 29, 2023 – Starting price will be the closing price of the IPO.
Picks submitted after January 29, 2022 are welcome – A 20% penalty of the closing price.
Short share price – Price when delisted plus a 20% penalty of the closing price.
A reverse split, split, or, symbol change – OK if you let us know prior to or on January 29, 2023. A 20% penalty for the extra research after January 29, 2023.
BlueWolf will continue to provide weekly comments and updates. Thank you BlueWolf.
Discussions and concerns are welcome. Good Luck!
-
I'll go with NVDA long.
Thank you both for doing this.
-
put me down for RAVE...thanks Bluewolf and JohnHenry for running such a fun contest.
=============================
I am HUGE! Bring me your finest meats and cheeses.
- $$$MR. MARKET$$$
-
I'll go with CMC. It's the top stock on my screen, and if there is any truth to those commodity supercycles, it should do very well over the next few years.
-
Make sure you state whether you want to be long or short. I’ll assume long for CMC and RAVE.
-
=============================
I am HUGE! Bring me your finest meats and cheeses.
- $$$MR. MARKET$$$
-
 Originally Posted by mrmarket
always long!
Gosh......
-
Gimme an O!
Gimme an M!
Gimme an E!
Gimme an G!
Gimme an A!
What's that spell? OMGA!
That's right, I do know how to spell, and I want to go long on Omega Therapeutics this year. Here's the scoop on OMGA:
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. Its OMEGA Epigenomic Programming platform harnesses the power of epigenetics, as well as the mechanism that controls gene expression and aspect of an organism's life. The company's platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a range without altering native nucleic acid sequences. Its modular and programmable mRNA medicines, and Omega Epigenomic Controllers are designed to target specific epigenomic loci within insulated genomic domains from genome-wide DNA-sequences with single or multiple genes to treat and cure diseases through Precision Genomic Control. The company is advancing a pipeline of development candidates covering a range of disease areas, including oncology, regenerative medicine, multigenic diseases, and select monogenic diseases. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
-
oh, yeah, and ALWAYS LONG!
-
Thread Information
Users Browsing this Thread
There are currently 1 users browsing this thread. (0 members and 1 guests)
Similar Threads
-
By JohnHenry in forum Discussion
Replies: 170
Last Post: 01-12-2023, 08:57 PM
-
By JohnHenry in forum Discussion
Replies: 174
Last Post: 01-03-2022, 09:39 PM
-
By JohnHenry in forum Discussion
Replies: 171
Last Post: 01-17-2021, 10:42 AM
-
By JohnHenry in forum Discussion
Replies: 71
Last Post: 01-01-2019, 08:00 PM
-
By JohnHenry in forum Discussion
Replies: 152
Last Post: 01-23-2018, 02:03 PM
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|

Do you like this site?
Take a look at the homepage of $$$ MR. MARKET $$$
|